Company intelligence
SERB Pharmaceuticals
SERB is a fast-growing global speciality pharma company designed to address rare and urgent conditions.
About SERB Pharmaceuticals
Critical needs. Immediate action. SERB Pharmaceuticals exists for critical medical moments. We deliver life-saving medicines for rare and urgent conditions — when time, reliability, and execution make all the difference. By combining biotech agility with global pharma reliability, we operate end-to-end across 100+ countries, ensuring 70+ essential medicines reach patients and clinicians wherever and whenever they’re needed. Powered by purpose. Driven by passionate people who go the extra mile.
Verified activity
Signals from SERB Pharmaceuticals
10 published signals
Presence & Recognition
SERB Pharmaceuticals welcomed Lindsey Burrow to share her personal experience of being a caregiver to her husband, former rugby league player Rob Burrow, and the realities of caring for a loved one suffering from rare disease.
Reported by SERB Pharmaceuticals
People
SERB Pharmaceuticals welcomed Sara Dupouy as the new VP, Head of HR Europe and International.
Reported by SERB Pharmaceuticals
People
SERB Pharmaceuticals senior scientist Lenon Nyatsungo discusses the role and responsibilities of the CMC team, career progression, and social culture at the Wales site.
Reported by SERB Pharmaceuticals
Presence & Recognition
SERB Pharmaceuticals is participating in the first edition of the DEPHI Rouge solidarity race dedicated to blood diseases taking place on Sunday 13 September 2026 at Hôpital Saint-Louis in Paris.
Reported by SERB Pharmaceuticals
Strategy & Corporate Development
SERB Pharmaceuticals joined the team following Hansa Biopharma's out-licensing of kidney transplant medicine in the UK, European Union, Switzerland, Norway, Liechtenstein, Iceland, and the MENA region.
Reported by Hannah Saul
Presence & Recognition
SERB Pharmaceuticals participated in the 2026 Fall IDN Summit, engaging in discussions about Rare Oncology and Rare Emergency Medicine.
Reported by SERB Pharmaceuticals
Presence & Recognition
SERB Pharmaceuticals is attending the ETA2026 event hosted by the European Thyroid Association to meet with physicians and members of the scientific community at Booth B20.
Reported by SERB Pharmaceuticals
People
SERB Pharmaceuticals welcomed new colleagues through a recent acquisition.
Reported by Vanessa Wolfeler
Presence & Recognition
SERB Pharmaceuticals joined the global community in raising awareness and recognising organisations working to improve care for patients throughout September.
Reported by SERB Pharmaceuticals
Presence & Recognition
SERB Pharmaceuticals is attending the 2026 Fall IDN Summit to connect with the team and learn about work in Rare Oncology and Rare Emergency Medicine.
Reported by SERB Pharmaceuticals